How Long Does Marijuana Stay in the Body? THC Pharmacokinetics and Drug Testing

A scientific-educational article on the pharmacokinetics of tetrahydrocannabinol (THC) in the human body. The content is for informational purposes only and does not constitute medical or legal advice. In Poland, marijuana remains illegal under Article 62 of the Act of July 29, 2005, on counteracting drug addiction, and driving under the influence of a narcotic is penalized by Article 178a of the Penal Code. We do not provide advice on how to circumvent drug tests or methods for falsifying laboratory test results.

The question of "how long marijuana stays in the body" is one of the most frequently asked by medical patients, individuals undergoing sobriety checks, and clinicians interpreting toxicology test results. The answer is not simple and never states "X days." Tetrahydrocannabinol exhibits unique pharmacokinetics among psychoactive substances, combining rapid elimination from the blood with weeks of accumulation in fatty tissue. In this guide, we analyze each stage of the process, relying solely on peer-reviewed scientific literature and SAMHSA guidelines. We will discuss absorption, distribution, metabolism, elimination, types of tests, and individual factors. We will also explain why popular "detox methods" lack support in clinical data.

What is THC and why does it stay in the body for so long?

Delta-9-tetrahydrocannabinol (THC) is the main psychoactive cannabinoid in cannabis, with exceptionally high lipophilicity (log P around 6.97) and a volume of distribution reaching 10 l/kg of body weight. This physicochemical characteristic causes THC to bind to lipid membranes and fat tissue, creating a reservoir that releases the substance over many days (Grotenhermen, Clinical Pharmacokinetics, 2003).

Chemical structure and lipophilicity

The THC molecule (C21H30O2, mass 314.47 g/mol) contains a terpenophenolic structure with a long pentyl chain. This structure explains its practically zero solubility in water (2.8 mg/l) and high solubility in lipids. In plasma, THC binds 95-99% to lipoproteins and albumin, which limits the free fraction available for elimination. This distribution fundamentally distinguishes THC from alcohol, which distributes evenly in body water and is eliminated in zero-order kinetics.

Storage in fat tissue (depot effect)

Fatty tissue acts as a "storage" for THC. Autopsy studies of chronic users show THC concentrations in fatty tissue up to 200-fold higher than in plasma. Release from these depots occurs slowly and irregularly, especially during lipolysis (e.g., fasting, intense exercise, weight loss). This explains the detection of metabolites in urine even 60-80 days after abstinence in regular users.Ellis, PMC, 1985).

According to Grotenhermen (Clinical Pharmacokinetics, 2003), THC has a volume of distribution of about 10 l/kg and binds 95-99% to plasma proteins. Its lipophilicity (log P 6.97) causes accumulation in fat tissue, where concentrations can exceed plasma levels by up to 200 times, explaining the multi-day detection time of metabolites.

pillar on the pharmacokinetics of CBD and THC

How is THC absorbed? Inhalation versus oral intake

The bioavailability of THC varies drastically depending on the route of administration: inhalation provides 10-35% bioavailability with a rapid increase in concentration (Cmax in 3-10 minutes), while the oral route yields only 4-20% bioavailability with a delayed peak (1-4 hours). This difference affects the intensity of the effect and the detection window (Huestis, Chemistry & Biodiversity, 2007).

Inhalation absorption

When smoked or vaporized, THC crosses the alveolar-capillary barrier within seconds. Plasma concentration peaks (usually 50-200 ng/ml) within 3-10 minutes of inhalation. Bioavailability depends on the smoking technique, the number and depth of "puffs," the duration of smoke retention, and loss during side burning. Vaporization increases bioavailability to 30-35% compared to 10-25% when smoking a classic joint.Newmeyer, Clinical Chemistry, 2016).

Oral absorption and first-pass effect

After oral consumption, THC passes through the intestinal wall and enters the portal vein to the liver, where it undergoes intense first-pass metabolism. This delays peak concentration to 1-4 hours, and bioavailability drops to 4-20%. At the same time, more 11-OH-THC, a strongly psychoactive metabolite, is produced, which explains the more intense subjective effects at the same dose consumed in food compared to inhalation.

Sublingual and mucosal administration

Sublingual formulations (e.g., Sativex, nabiximols) partially bypass the first-pass effect. Bioavailability reaches 13-28%, with a peak occurring after 45-120 minutes. This route is significant in a medical context, where it is used in the treatment of spasticity in multiple sclerosis.

How does the body metabolize THC? The role of CYP2C9 and CYP3A4

THC is primarily metabolized in the liver by cytochrome P450 isoenzymes, mainly CYP2C9 (~75% of metabolism) and CYP3A4 (~25%). The first active metabolite is 11-hydroxy-THC (11-OH-THC), followed by the formation of 11-nor-9-carboxy-THC (THC-COOH), which is pharmacologically inactive but crucial in laboratory diagnostics (Watanabe, Life Sciences, 2007).

Stage I: hydroxylation to 11-OH-THC

CYP2C9 catalyzes the hydroxylation of the allylic carbon C-11, forming 11-OH-THC. This metabolite is psychoactive and may even be stronger than the parent molecule at CB1 receptors. A higher ratio of 11-OH-THC to THC in plasma (above 20%) often suggests oral intake, which is significant in forensic expertise reconstructing the circumstances of use. A ratio below 10% typically indicates inhalation.

Stage II: oxidation to THC-COOH and conjugation with glucuronic acid

11-OH-THC is oxidized to 11-nor-9-carboxy-Δ9-THC (THC-COOH), an inactive metabolite that predominates in urine. THC-COOH undergoes conjugation with glucuronic acid by UGT1A9 and UGT2B7, forming water-soluble THC-COOH-glucuronide excreted in urine. Most immunochemical tests detect this metabolite.

Genetic variants of CYP2C9

Polymorphisms CYP2C9*2 (rs1799853) and CYP2C9*3 (rs1057910) significantly affect THC clearance. Carriers of the CYP2C9*3/*3 allele exhibit THC clearance reduced by 30-40% and higher plasma exposures after the same dose, leading to longer detection times (Sachse-Seeboth, Clinical Pharmacology & Therapeutics, 2009). This means that two individuals of identical weight and frequency of use may have significantly different test results.

THC metabolism primarily occurs through CYP2C9 (about 75%) and CYP3A4 (about 25%), producing active 11-OH-THC and inactive THC-COOH. Sachse-Seeboth (Clinical Pharmacology & Therapeutics, 2009) demonstrated that homozygotes for CYP2C9*3 have THC clearance reduced by 30-40%, extending the detection time of metabolites in urine.

How long is THC eliminated from the body?

Elimination of THC and its metabolites occurs mainly through feces (about 65%) and urine (about 20-30%), with the remaining 5-15% eliminated by other routes, including sweat and hair. The elimination half-life of THC in plasma is biphasic: a rapid alpha phase of about 30 minutes, and a slow beta phase lasting 20-30 hours for occasional users and 3-13 days for chronic users (Huestis, PMC, 2013).

Elimination via feces and enterohepatic circulation

About 65% of the THC dose is excreted in feces, mainly as unconjugated THC-COOH and THC. A significant portion of metabolites enters the bile and then the small intestine, where they undergo enterohepatic circulation. Gut bacteria deglucuronidate conjugated THC-COOH, allowing for reabsorption and prolonging the time of presence in the body.

Elimination via urine

About 20-30% of the dose leaves the body through the kidneys, almost exclusively as THC-COOH-glucuronide. Free THC in urine is negligible (usually below 0.1%). Therefore, classic urine tests measure not active THC but its inactive metabolite, which is fundamental for interpretation: a positive test does not indicate current impairment or recent use.

Other routes: sweat, saliva, hair

Sweat contains trace amounts of THC (without THC-COOH), used in continuous clinical monitoring via so-called sweat patches. Hair accumulates THC and metabolites from the blood during the growth of the hair follicle, allowing for retrospective analysis of months of exposure. Saliva mainly contains THC from direct contact with the oral cavity during inhalation, not from the bloodstream.

How long is marijuana detectable in urine?

Urine testing is the most common method for detecting cannabis in Poland and worldwide. According to a meta-analysis published in the Journal of Analytical Toxicology, at a threshold of 50 ng/ml THC-COOH, an occasional user remains positive for 3-4 days, a regular user for 5-7 days, and a chronic daily user for even 30-67 days after cessation of use (Smith-Kielland, Journal of Analytical Toxicology, 1999).

SAMHSA thresholds: 50 ng/ml and 15 ng/ml

SAMHSA (Substance Abuse and Mental Health Services Administration, USA) defines the standard threshold for the screening test at 50 ng/ml THC-COOH, and for the confirmatory test (GC-MS or LC-MS/MS) at 15 ng/ml. Polish laboratories typically use the same reference values. Lower thresholds, 20 ng/ml or 10 ng/ml, significantly extend detectability (SAMHSA Mandatory Guidelines, 2017).

Detection time depending on the pattern of use

• Single use (naive user): 1-3 days at a threshold of 50 ng/ml; 3-8 days at a threshold of 15 ng/ml.
• Occasional use (1-3 times a week): 3-7 days at a threshold of 50 ng/ml; 7-14 days at 15 ng/ml.
• Regular use (several times a week): 7-21 days at a threshold of 50 ng/ml.
• Chronic daily use: 15-30 days, often up to 45-60 days, occasionally up to 77 days documented in studies (Huestis, PMC, 2013).

Immunochemical test versus GC-MS confirmation

Immunochemical tests (EMIT, CEDIA, strip tests) are inexpensive and quick, but prone to cross-reactivity and false positive results (including from some NSAIDs like efavirenz, dronabinol, rifampicin). A positive result requires confirmation by chromatographic-mass spectrometry (GC-MS or LC-MS/MS), which identifies the specific THC-COOH molecule with a sensitivity below 1 ng/ml. In practice, the percentage of positive results in the screening test that do not confirm in GC-MS in Polish laboratories is about 5-10%.

The standard threshold for the urine test is 50 ng/ml THC-COOH (screening) and 15 ng/ml (confirmatory GC-MS). At a threshold of 50 ng/ml, occasional users remain positive for 3-7 days, and chronic users for up to 30-67 days (Smith-Kielland, Journal of Analytical Toxicology, 1999).

How long is marijuana detectable in blood?

Blood tests measure active THC (not metabolites) and are the closest indicator of current substance influence. In occasional users, THC disappears from the blood within 6-24 hours after inhalation, while in chronic users, it may remain at low levels (1-3 ng/ml) for 7-30 days due to slow release from fat tissue (Karschner, Addiction, 2009).

Phases of THC elimination from blood

After inhalation, THC concentration in plasma rises sharply (peak 50-200 ng/ml) and then decreases in two phases. The distribution phase alpha (about 30 minutes) reflects rapid redistribution to tissues, including the brain and fat tissue. The elimination phase beta lasts 20-57 hours in naive users and 3-13 days in chronic users. After dropping below the threshold of 1 ng/ml, the substance practically no longer affects cognitive functions.

Road tests versus laboratory results

Polish saliva roadside tests (Drager DrugTest, Alere DDS2) indicate suspicion of THC presence above the threshold. A positive result serves as a basis for detention and blood sampling for laboratory testing in a certified unit. In the procedural practice of Polish cases under Article 178a of the Penal Code, experts interpret THC concentrations in blood above 1-2 ng/ml as indicating possible impairment, although the correlation between concentration and actual impairment is much weaker than in the case of alcohol.

How does the blood result differ between an occasional and chronic user?

The study by Karschner et al. showed that five out of 25 chronic users had detectable THC in their blood (above 0.5 ng/ml) even after 7 days of abstinence, and two after 30 days. In naive users, this same threshold was not exceeded after 24 hours (Karschner, Addiction, 2009). This is a fundamental argument against interpreting any positive THC concentration as evidence of "recent use."

Karschner et al. (Addiction, 2009) showed that 20% of chronic cannabis users had detectable THC in their blood after 7 days of abstinence, and 8% after 30 days. This means that a positive blood result does not prove recent use or current impairment, especially in regular users.

How long does marijuana stay in saliva?

Saliva tests typically detect THC for 24-72 hours after inhalation, with a shorter detection window for occasional users (up to 24 hours) and longer for chronic users (up to 72 hours at a threshold of 2 ng/ml). The SAMHSA threshold for saliva is 4 ng/ml THC (screening) and 2 ng/ml (confirmatory) (Newmeyer, Clinical Chemistry, 2016).

Mechanism of THC presence in saliva

Unlike urine, THC in saliva mainly comes from deposition during inhalation, not from filtration from the blood. After oral consumption, the detection time in saliva is significantly shorter. Salivary glands have a limited ability to filter lipophilic substances, which is why THC-COOH is detected in saliva in negligible amounts.

Application in road control

Saliva tests are the standard of modern road control in Europe, including Poland. Sensitivity at a threshold of 25 ng/ml (Drager 5000) is about 80-90%, and specificity is 95-99%. A positive result serves as the basis for detaining the driver, while the evidence in the proceedings remains the blood test in an accredited laboratory, usually by LC-MS/MS (NIDA DrugFacts, 2023).

How long is marijuana detectable in hair?

Hair tests can detect cannabis use up to 90 days back in a standard three-centimeter segment of hair (3 cm corresponds to about 3 months of growth), and longer samples allow for assessing multi-year exposure. The cutoff threshold for THC is typically 0.05 ng/mg of hair (Society of Hair Testing guidelines) (Musshoff, Journal of Analytical Toxicology, 2006).

Mechanism of THC incorporation into hair

THC and its metabolites enter the hair matrix from the bloodstream through the hair follicle and from sweat and sebum on the surface of the scalp. The cortical layer of the hair stably stores the substance throughout the hair's life. Hair segmentation (most often 3 cm from the bulb) allows for estimating the time of exposure, as head hair grows on average 1 cm per month.

Limitations of hair testing

The main weakness is the risk of passive contamination (being in a room with cannabis smoke). Therefore, the Society of Hair Testing guidelines require confirmation of the presence of THC-COOH at a threshold of 0.05 pg/mg, as this metabolite is produced exclusively in the body and cannot come from external contamination. Dark hair binds melanin more strongly than light hair, which in some ethnically diverse populations may yield falsely higher concentrations (bias from dyeing and pigmentation).

When is hair testing used?

Hair testing is used in civil cases (child custody, divorce cases), assessments of abstinence for drivers regaining their licenses, as well as in criminal toxicology and identifying long-term patterns of use. It is rarely used in routine employee testing due to higher costs (typically 400-800 PLN) and complicated interpretation.

Hair tests detect cannabis use up to 90 days back in a standard 3 cm segment, with a threshold of 0.05 ng/mg THC according to the Society of Hair Testing. Musshoff (Journal of Analytical Toxicology, 2006) indicates that confirmation of THC-COOH is essential to distinguish use from passive contamination by cannabis smoke.

What individual factors affect the detection time of marijuana?

Individual variability in THC detection time can reach up to 10-fold between individuals. The study by Goodwin et al. showed that among 60 chronic users, the time to return to a negative urine test at a threshold of 50 ng/ml ranged from 3 to 77 days, with a median of 27 days (Goodwin, PMC, 2008).

Frequency and pattern of use

The most important single factor. Daily users accumulate THC in fat tissue many times more than occasional users, creating a multi-component depot that releases the substance for weeks. Even with identical body weight and diet, the difference in detection time between a person smoking daily and once a month can reach 10-fold.

BMI and percentage of body fat

A higher percentage of body fat increases the depot capacity for THC. Studies show that individuals with a BMI above 30 kg/m^2 may have a detection time in urine 20-40% longer than lean individuals with a similar pattern of use. Women generally have a higher percentage of body fat, which translates to slightly longer detection windows.

Physical activity and lipolysis

Paradoxically, intense physical exercise can temporarily raise THC-COOH levels in plasma due to lipolysis releasing THC from fat depots. The study by Wong et al. showed that 35 minutes of aerobic exercise in chronic users raised plasma THC levels by an average of 15%, peaking 2 hours after exercise (Wong, Drug and Alcohol Dependence, 2013). Long-term physical activity accelerates elimination, but short-term may "unmask" stored THC.

Age, sex, and liver function

Younger individuals generally have faster metabolism, but individual differences within an age group are usually greater than between groups. Chronic liver diseases (cirrhosis, hepatitis) reduce THC clearance by decreasing CYP2C9 activity. Kidney diseases mainly affect the elimination of metabolites through urine, not necessarily prolonging total presence in the body.

Urine pH and hydration

The pH of urine has a marginal effect on the excretion of THC-COOH (pKa constant around 4.5), as the metabolite is excreted in the form of a glucuronide. Hydration increases urine volume and may dilute the concentration of THC-COOH below the detection threshold; however, laboratories routinely measure creatinine and specific gravity, rejecting samples below 20 mg/dl creatinine as "diluted."

Does "detox" and niacin really remove THC from the body?

No dietary supplement, detox drink, or dose of niacin has scientifically documented effects that accelerate the elimination of THC from the body. A systematic review by Cone and Huestis in Clinical Chemistry (2007) identified 18 studies on so-called detox products, and none showed effectiveness higher than placebo in reducing THC-COOH concentrations in urine (Cone, Clinical Chemistry, 2007).

Myth: detox drinks

Products like „Mega Clean” or „QCarbo” mainly contain caffeine, B vitamins, creatinine, and diuretic herbs. Their action is based on diluting urine and artificially supplementing creatinine so that the sample is not rejected as „diluted”. Modern laboratories detect manipulations by measuring the pattern of uric acid, urea, and electrolytes. Paradoxically, intensive use of these products increases the risk of detection of fraud more than refraining from any actions.

Myth: niacin (vitamin B3)

There is a belief circulating on the internet that high doses of niacin (500-2000 mg) "release" THC from fat tissue. There is no pharmacological mechanism supporting this view. A series of cases in the Annals of Emergency Medicine described hospitalizations due to hepatotoxicity and metabolic acidosis after massive doses of niacin taken before a drug test (Mittal, Annals of Emergency Medicine, 2007).

Myth: intense exercise and sauna

As previously described, short-term exercise raises plasma THC levels due to lipolysis. Long-term physical activity reduces body fat percentage, which over time decreases the THC depot, but this effect requires weeks of regular training, not hours before a test. Sauna does not significantly increase THC elimination clinically, as sweat contains trace amounts of the substance.

What works? Time and abstinence

The only reliable method of "cleansing" the body is abstinence. For occasional users, this is 5-10 days, for regular users 2-4 weeks, and for chronic users even 6-10 weeks. Reducing body fat by 5-10% through a caloric deficit and regular exercise can further shorten this period, but it cannot replace the fundamental mechanism, which is the passage of time.

Cone and Huestis (Clinical Chemistry, 2007) in a review of 18 studies on "detox" did not identify any product that effectively reduced THC-COOH levels in urine more than placebo. Massive doses of niacin are associated with hepatotoxicity and hospitalizations (Mittal, Annals of Emergency Medicine, 2007).

Legal status in Poland: positive test and consequences

In Poland, possession of marijuana remains a crime under Article 62 of the Act of July 29, 2005, on counteracting drug addiction, punishable by up to 3 years of imprisonment. Driving a vehicle "under the influence" or "while impaired" by a narcotic is penalized under Article 178a of the Penal Code, and the court may impose a driving ban from 1 year to 15 years (ISAP, Act on Counteracting Drug Addiction, 2005).

The difference: "under the influence" versus "while impaired"

Polish criminal law distinguishes between two states of intoxication. "State after use" (Article 87 of the Misdemeanor Code) includes THC concentrations in blood from 1 to 2.5 ng/ml; a misdemeanor punishable by a fine of up to 5000 PLN and a driving ban from 6 months to 3 years. "State under the influence" (Article 178a of the Penal Code) is assumed above 2.5 ng/ml THC; a crime punishable by up to 3 years of imprisonment. These limits were established based on the Announcement of the Attorney General from 2013.

Road tests: suspicion versus confirmation

The saliva test during a road check indicates only suspicion of the presence of THC. The evidence in the proceedings is solely the blood test in an accredited facility (most often the Institute of Forensic Expertise in Krakow or the forensic medicine department). A positive saliva test does not, by itself, constitute grounds for conviction without laboratory confirmation.

Medical marijuana patients and road law

Legal use of medical marijuana (Act of July 7, 2017) does not exempt from liability under Article 178a of the Penal Code. A patient using THC according to a doctor's prescription who drives with a concentration of 3 ng/ml in the blood formally commits a crime. The Supreme Court has emphasized in several rulings that liability is objective, regardless of the legality of the source of the substance (cf. Supreme Court ruling V KK 104/15).

What to do after a positive test?

In the case of a positive roadside test or legal dispute, it is advisable to consult a lawyer or legal advisor specializing in criminal law immediately. In procedural practice, there is room for a defense based on the analysis of the elimination curve and demonstrating that the concentration at the time of testing did not correspond to the state at the time of the act, especially in chronic users. We do not provide advice on circumventing drug tests or falsifying results.

article on the current legal status of cannabis

Alternative cannabis products with zero or minimal THC content

Products containing cannabidiol (CBD) and cannabigerol (CBG) derived from industrial hemp contain a maximum of 0.3% THC under the 2022 Act, which in most cases does not lead to positive drug tests at standard doses. The study by Lachenmeier et al. showed that taking 200 mg of CBD daily for 10 days did not result in exceeding the threshold of 15 ng/ml THC-COOH in urine (Lachenmeier, European Food Safety Authority, 2019).

CBD and CBG products in the broad spectrum category

Broad spectrum oils contain hemp cannabinoids with THC removed, which practically eliminates the risk of a positive marijuana test at the recommended dosage. They are intended to support daily relaxation and mental comfort as part of dietary supplementation, not for treating specific medical conditions.

Caution with full spectrum formulations

Full spectrum CBD oils contain trace amounts of THC (up to 0.2-0.3%). At extremely high doses (above 1000 mg of CBD daily), there is a theoretical risk of a positive urine test, especially at a low cutoff threshold. For individuals undergoing regular testing (professional drivers, machine operators), broad spectrum products or CBD isolates (zero THC) are a safer choice.

Selected products available in the u Bucha store

• SOOL Broad Spectrum CBD 5% 10 ml (76 PLN) – oil with a mild profile, 500 mg CBD in a bottle, no detectable THC.
• SOOL Broad Spectrum CBD 10% 10 ml (99 PLN) – stronger oil, 1000 mg CBD, broad spectrum without THC.
• Cannova CBG 15% 10 ml (240 PLN) – oil with cannabigerol 1500 mg, shows no affinity for CB1 receptors responsible for the psychoactive effect.
• Mars CBD Hemp Herb 9% (59 PLN) – hemp flower compliant with Polish THC limits below 0.3%, intended for vaporization.

All listed products are available to adult consumers as non-medical products; they do not replace medical advice or treatment.

broad spectrum store category

Frequently asked questions

Can I drink coffee or vitamin C to eliminate marijuana faster?

No. The review by Cone and Huestis (Clinical Chemistry, 2007) covering 18 studies on detox products found no substance more effective than placebo. Caffeine has a diuretic effect but does not affect THC clearance. Vitamin C does not interfere with CYP2C9 metabolism. The only method to remove THC is abstinence and time.

How much THC must be in the blood to be convicted in Poland?

Poland adopts the limits set in the General Prosecutor's announcement from 2013: 1-2.5 ng/ml THC in blood is a misdemeanor (Article 87 of the Misdemeanor Code, penalty up to 5000 PLN fine), above 2.5 ng/ml is a crime (Article 178a of the Penal Code, up to 3 years imprisonment). The result is confirmed by laboratory testing in an accredited unit.

Can CBD give a positive marijuana test?

Under normal conditions, no. The study by Lachenmeier (EFSA, 2019) showed that 200 mg of CBD daily for 10 days did not exceed the threshold of 15 ng/ml THC-COOH in urine. There is a risk with full spectrum oils containing up to 0.3% THC and doses above 1000 mg of CBD daily. Broad spectrum oils and isolates eliminate this risk practically to zero.

Why does a chronic user have a positive urine test after a month of abstinence?

Due to THC accumulation in fat tissue. The study by Goodwin (PMC, 2008) showed a median of 27 days and a maximum of 77 days for the return to a negative test among 60 daily users. THC is released from fat depots over weeks, especially during lipolysis caused by exercise, fasting, or weight loss.

Will a saliva test detect marijuana smoked yesterday?

Yes, usually. Newmeyer (Clinical Chemistry, 2016) showed that at a threshold of 2 ng/ml THC, the detection window in saliva is 24-72 hours after inhalation in occasional users and up to 72 hours in chronic users. If the saliva test during a road check is positive, a blood confirmation test is always performed in the laboratory.

Will intense training before the test help or hurt?

It is more likely to hurt in the short term. Wong et al. (Drug and Alcohol Dependence, 2013) showed that 35 minutes of aerobic exercise raised plasma THC levels by an average of 15% in chronic users, peaking 2 hours after completion. Long-term regular activity reduces body fat, accelerating elimination, but the effect requires weeks, not hours.

Can medication give a false positive result on a marijuana test?

Yes, but the confirmatory GC-MS result usually identifies this. Some non-steroidal anti-inflammatory drugs (ibuprofen, naproxen), protease inhibitor efavirenz, pantoprazole, dronabinol, and rifampicin can cause cross-reactivity in immunochemical tests. The confirmatory GC-MS specifically identifies the THC-COOH molecule, eliminating false positive results.

How long does it take to return to a negative test after one joint?

For a non-daily smoker (naive user), typically 3-8 days at a threshold of 50 ng/ml in urine and up to 14 days at a lower threshold of 15 ng/ml. Huestis (PMC, 2013) indicates that in 90% of such individuals, the urine result returns to negative within 7-10 days after a single inhalation, while in blood, THC disappears within 6-24 hours, and in saliva within 12-24 hours.

Summary: what is really worth remembering?

The time marijuana remains in the body depends on the route of administration, usage pattern, individual biology, and type of test. Active THC disappears from the blood within hours for occasional users, but its inactive metabolite THC-COOH can be detected in urine for weeks in chronic users. No "detox," drink, or niacin significantly shortens this process; only abstinence and time work. In Poland, driving with THC levels above 2.5 ng/ml in the blood constitutes a crime under Article 178a of the Penal Code, regardless of the legality of the source of the substance.

If you are looking for legal cannabis products without psychoactive effects, it is worth exploring the categories of broad spectrum CBD oils and CBG, which do not cause positive marijuana tests at recommended dosages. In case of legal issues related to drug testing, it is advisable to consult a lawyer specializing in criminal law.

on the pharmacokinetics of cannabinoids

---

About the author: Michał Waluk, cannabis educator and author of the u Bucha blog. The article was prepared based on peer-reviewed scientific literature (PMC, Clinical Pharmacokinetics, Journal of Analytical Toxicology, Clinical Chemistry) and SAMHSA guidelines.

Sources:

• Grotenhermen F. (2003). Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clinical Pharmacokinetics, 42(4):327-360.
• Huestis MA. (2007). Human Cannabinoid Pharmacokinetics. Chemistry & Biodiversity, 4(8):1770-1804.
• Huestis MA, Smith ML. (2013). Cannabinoid Markers in Biological Fluids and Tissues. PMC3784291.
• Sachse-Seeboth C et al. (2009). Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol. Clinical Pharmacology & Therapeutics, 85(3):273-276.
• Karschner EL et al. (2009). Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction, 104(12):2041-2048.
• Newmeyer MN et al. (2016). Free and Glucuronide Whole Blood Cannabinoids Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration. Clinical Chemistry, 62(12):1579-1592.
• Musshoff F, Madea B. (2006). Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use. Journal of Analytical Toxicology.
• Cone EJ, Huestis MA. (2007). Interpretation of oral fluid tests for drugs of abuse. Clinical Chemistry.
• Wong A et al. (2013). Exercise increases plasma THC concentrations in regular cannabis users. Drug and Alcohol Dependence, 133(2):763-767.
• Goodwin RS et al. (2008). Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. PMC.
• Mittal MK et al. (2007). Toxicity from the use of niacin to beat urine drug screening. Annals of Emergency Medicine, 50(5):587-590.
• SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs (2017).
• The Act of July 29, 2005, on counteracting drug addiction, Journal of Laws 2005 No. 179, item 1485.